Randomised Controlled Trial to Evaluate the Preventive Effect on Mortality and Serious Morbidity/ Hospitalisations of Daily Vitamin D Supplements in Small for Gestational Age Term Infants
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 2,000
- 试验地点
- 1
- 主要终点
- Mortality
研究概览
简要总结
The purpose of this study is to determine whether a weekly supplement of vitamin D to low birth weight term infants will reduce their mortality and hospital admissions and improve their immunity.
详细描述
We are conducting a randomised controlled trial of weekly oral vitamin D supplements to low birth weight (< 2.5 kg) term infants born in a large government hospital catering to a low-middle income population in Delhi. Mothers and infants are recruited at delivery and given weekly vitamin D supplements or placebo until 6 months of age. Data on infant morbidity, sun exposure and diet, with particular emphasis on breast milk and other milk intake, is collected by fieldworkers visiting the homes each fortnight. Mothers are encouraged to bring their infants to the hospital in case of any illness and at these visits the infant is seen by the project doctor who treats the infant and records additional morbidity data. At 6 months blood samples are being collected from a 20% random subsample of infants for measurement of 25OHD and indicators of immune activation. The primary outcome is mortality or incidence of any illness requiring admission to hospital.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Prevention
- 盲法
- Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
入排标准
- 年龄范围
- 24 Hours 至 2 Days(Child)
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •Born at term, as determined from last menstrual period
- •Weighing < 2.5 kg
- •Resident within 12 km of the hospital and expected to continue living in the area for the following 6 months
- •With no severe congenital abnormalities
- •No morbidity severe enough to be expected to result in death before 7 days due to severe respiratory distress, shock, pulmonary sepsis, etc.
- •Parental informed consent
排除标准
- 未提供
研究组 & 干预措施
Vitamin D3
vitamin D granules
干预措施: Vitamin D3 (Drug)
结局指标
主要结局
Mortality
时间窗: weekly
Incidence of disease requiring hospitalization
Morbidity and hospitalization
时间窗: weekly
次要结局
- Incidence of infectious disease not requiring hospitalization
- Severe morbidity requiring hospitalization
研究者
Dr Geeta Trilok-Kumar
Associate professor
Delhi University
